# FDA Inspection 1081599 - Biomat USA, Inc - February 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d5c7da61-e6ea-4e6a-99ab-478e8c1e9bfb
Source feed: FDA_Inspections

> FDA Inspection 1081599 for Biomat USA, Inc on February 20, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081599
- Company Name: Biomat USA, Inc
- Inspection Date: 2019-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 950707 - 2015-12-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6cafdf5f-b894-43fa-a3af-08bb317a6e29)
- [FDA Inspection 829227 - 2013-04-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c6d225de-9380-4737-b0d5-cce3f983e78b)
- [FDA Inspection 744307 - 2011-09-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bccd8407-2bc9-4961-9fa1-ed631bb66f2a)
- [FDA Inspection 620238 - 2009-07-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5098dcd7-7b34-4217-8b7e-2b9bb8660b5a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/f8858c09-dab1-4ae6-b21b-9ef9d2392b11

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d